Drugs developed to treat diabetes may offer new approach against … – The Japan Times

LONDON Having become popular with both celebrities and investors, diabetes drugs that also promote weight loss, such as Novo Nordisks Ozempic, are now being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimers disease.

Diabetes regimens, from Ozempic to old mainstays like insulin and metformin, appear to address several different aspects of the metabolic system implicated in Alzheimer's disease, including a protein called amyloid and inflammation, researchers say.

The hope is that improving glucose use and tamping down inflammation in the entire body including the brain could slow progression of debilitating diseases like Alzheimer's and Parkinson's.

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this FAQ.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.By subscribing, you can help us get the story right.

See the original post here:
Drugs developed to treat diabetes may offer new approach against ... - The Japan Times